Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Epidemiology of Venous Thromboembolism

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by:
Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT00456196
First received: April 2, 2007
Last updated: July 9, 2009
Last verified: July 2009
  Purpose

More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE Prophylaxis.


Condition
Venous Thromboembolism
Pulmonary Embolism
Cancer
Deep Vein Thrombosis
COPD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database

Resource links provided by NLM:


Further study details as provided by Brigham and Women's Hospital:

Enrollment: 5451
Study Start Date: April 2006
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients from the DVT FREE study with ultrasound-confirmed deep vein thrombosis

Criteria

Inclusion Criteria:

  • Ultrasound-confirmed DVT patients from 183 institutions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00456196

Locations
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women's Hospital
Sanofi
Investigators
Principal Investigator: Samuel Z. Goldhaber, MD Brigham and Women's Hospital
  More Information

Additional Information:
Publications:
Responsible Party: Samuel Z. Goldhaber, MD, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT00456196     History of Changes
Other Study ID Numbers: 2006-P-000820
Study First Received: April 2, 2007
Last Updated: July 9, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Brigham and Women's Hospital:
Deep Vein Thrombosis
COPD
Thrombosis
Cancer
Renal
Elderly
Surgery
Orthopedic Surgery
Medically Ill
Pulmonary Embolism
Anticoagulation

Additional relevant MeSH terms:
Venous Thromboembolism
Venous Thrombosis
Embolism
Pulmonary Embolism
Thromboembolism
Thrombosis
Cardiovascular Diseases
Embolism and Thrombosis
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on November 27, 2014